References
- Helsel BC , WilliamsJE , LawsonK , LiangJ , MarkowitzJ. Telemedicine and mobile health technology are effective in the management of digestive diseases: a systematic review. Dig. Dis. Sci.63(6), 1392–1408 (2018).
- Balasubramanian D , YoongJ , VrijhoefHJM. Telephone support and adherence in patients with chronic disease – a qualitative review of reviews. Smart Homecare Tech. Tele Health3, 107–118 (2015).
- Inglis SC , ClarkRA , DierckxR , Prieto-MerinoD , ClelandJG. Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database Syst. Rev. (10), CD007228 (2015).
- Kroenke K , KrebsEE , WuJ , YuZ , ChumblerNR , BairMJ. Telecare collaborative management of chronic pain in primary care: a randomized clinical trial. JAMA312(3), 240–248 (2014).
- McGeary DD , McGearyCA , GatchelRJ. A comprehensive review of telehealth for pain management: where we are and the way ahead. Pain Pract.12(7), 570–577 (2012).
- Lawrence R , MogfordD , ColvinL. Systematic review to determine which validated measurement tools can be used to assess risk of problematic analgesic use in patients with chronic pain. Br. J. Anaesth.119, 1092–1109 (2017).
- Adams LL , GatchelRJ , RobinsonRCet al. Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J. Pain Symptom Manage.27, 440–549 (2004).
- Holmes CP , GatchelRJ , AdamsLLet al. An opioid screening instrument: long-term evaluation of the utility of the pain medication questionnaire. Pain Pract.6, 74–88 (2006).
- Dowling LS , GatchelRJ , AdamsLL , StowellAW , BernsteinD. An evaluation of the predictive validity of the pain medication questionnaire with a heterogeneous group of patients with chronic pain. J. Opioid Manag.3, 257–266 (2007).
- Webster LR , WebsterRM. Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the opioid risk tool. Pain Med.6, 432–442 (2005).
- Witkin LR , DiskinaD , FernandesS , FarrarJT , AshburnMA. Usefulness of the opioid risk tool to predict aberrant drug-related behavior in patients receiving opioids for the treatment of chronic pain. J. Opioid Manag.9(3), 177–187 (2013).
- Jones T , LookatchS , MooreT. Validation of a new risk assessment tool: the brief risk questionnaire. J. Opioid Manag.11(2), 171–183 (2015).
- Butler SF , FernandezK , BenoitC , BudmanSH , JamisonRN. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J. Pain9(4), 360–372 (2008).
- Butler SF , BudmanSH , FanciulloGJ , JamisonRN. Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy. Clin. J. Pain26(9), 770–776 (2010).
- Butler SF , BudmanSH , FernandezKCet al. Development and validation of the current opioid misuse measure. Pain130(1-2), 144–156 (2007).
- Meltzer EC , RybinD , SaitzRet al. Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM). Pain152(2), 397–402 (2011).
- Brown J , SetnikB , LeeKet al. Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting. J. Opioid Manag.7(6), 467–483 (2011).